Sumitomo Mitsui Trust Holdings, Inc. Veracyte, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,493,377 shares of VCYT stock, worth $111 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,493,377
Previous 2,752,383
9.41%
Holding current value
$111 Million
Previous $93.7 Million
5.42%
% of portfolio
0.07%
Previous 0.07%
Shares
24 transactions
Others Institutions Holding VCYT
# of Institutions
309Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$346 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$344 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$223 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$219 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$188 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.18B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...